30 results about "Digestive cancer" patented technology

The invention discloses a health-care ginseng papaya lily glutinous rice dumpling. The dumpling is composed of the following ingredients, by weight: 93 to 100 parts of glutinous rice, 10 to 12 parts of hawthorn fruit powder, 36 to 46 parts of papaya, 1 to 2 parts of heartleaf houttuynia leaves, 3 to 4 parts of marsh marigold herbs, 1 to 3 parts of Japanese thistle roots, 8 to 10 parts of apple juice, 2 to 3 parts of polygonati rhizomes, 1 to 2 parts of common rush, 2 to 3 parts of glossy privet fruits, 1 to 2 parts of vegetable sponge of luffa, 3 to 4 parts of tree peony barks, 2 to 3 parts of gynostemma pentaphylla, 2 to 3 parts of pseudo-ginseng roots, 1 to 2 parts of hollyhock roots, 2 to 3 parts of licorice, and the balance being proper amount of excipients. The dumpling uses a mixture of Chinese herbal medicine extract and mulberry juice to improve the taste of a conventional dumpling wrapper produced from only glutinous rice and water, and makes the dumpling wrapper more nutrient. The papaya in the dumpling can help digestion, prevent and cure constipation, and prevent digestive cancer. The heartleaf houttuynia leaves, the glossy privet fruits, the gynostemma pentaphylla and the marsh marigold herbs all have some cancer-preventing effects, can be eaten frequently without any toxic and side effects, and can improve human immunity. Thus the dumpling is especially suitable for sub-health population to eat.

The invention discloses the application of aloperin in the preparation of drugs for treating digestive cancers. An anticancer test of aloperin on a plurality of human digestive system cancer cell strains is carried out in the invention, and the result shows that aloperin has an obvious anticancer effect and has a more excellent effect than sophoridine, which is the well-recognized antineoplastic active component of Sophora alopecuroides. Therefore, aloperin can be used to prepare pharmaceutical compositions for treating digestive system cancers, so as to provide new therapeutic candidate drugs for patients with digestive system cancers. In addition, enteric coated tablets of the pharmaceutical compositions for treating digestive system cancers in the invention avoid aloperin to be released in stomach and destroyed by gastric acid, so as to raise the stability of aloperin as well as the drug concentration of aloperin on affecting positions.